Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NiproTSE:8086 +0.39%70 PB Ratio is 0.92 as of Jul. 14, 2026, which is 23% below its 10-year median of 1.19. GuruFocus rates TSE:8086 with a GF Score™ of 70/100 and a GF Value™ of 円1,457.04 (Fairly Valued). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Nipro ranks better than 81.85% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-14), Nipro's share price is 円1552.50. Nipro's Book Value per Share for the quarter that ended in Mar. 2026 was 円1,680.70. Hence, Nipro's PB Ratio of today is 0.92.
The historical rank and industry rank for Nipro's PB Ratio or its related term are showing as below:
TSE:8086'
s PB Ratio Range Over the Past 10 Years
Min: 0.73 Med: 1.19 Max: 1.8
Current: 0.92
During the past 13 years, Nipro's highest PB Ratio was 1.80. The lowest was 0.73. And the median was 1.19.
TSE:8086's PB Ratio is ranked better than 81.85% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs TSE:8086: 0.92
During the past 12 months, Nipro's average Book Value Per Share Growth Rate was 8.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Nipro was 15.40% per year. The lowest was -7.90% per year. And the median was 1.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Nipro PB Ratio Related Terms
Nipro PB Ratio Historical Data
* Premium members only.
The historical data trend for Nipro's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nipro's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nipro PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nipro's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nipro's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Nipro's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Nipro (TSE:8086) has a PB Ratio of 0.92 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nipro and its competitors. This is 23% below median its historical median of 1.19. Over the past decade, Nipro's PB Ratio has ranged from 0.73 to 1.80. According to the industry distribution chart, Nipro ranks #143 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 18.1%.
Is Nipro's PB Ratio too high?
Nipro's current PB Ratio of 0.92 is 23% below median its 10-year median of 1.19. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 1.80. The Medical Devices & Instruments industry median PB Ratio is 2.05. Nipro's value of 0.92 is 55.1% below this industry median. Based on the distribution chart, Nipro ranks #143 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nipro has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nipro ranks #143 out of 788 companies for PB Ratio. This places Nipro in the top 18% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. Nipro's value of 0.92 is 55.1% below this benchmark. Historically, Nipro's own PB Ratio has ranged from 0.73 to 1.80 over the past decade. While the company's 10-year median is 1.19 vs. the industry median of 2.05, Nipro has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nipro's current PB Ratio of 0.92 is 55.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nipro and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nipro's current PB Ratio is 0.92, which is 23% below median its own 10-year median of 1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Fairly Valued. The stock's GF Value™ is 円1,457.04, compared to a current price of 円1,552.50 — trading 6.6% above its estimated fair value. The current PB Ratio is 0.92, which is 23% below median its 10-year median of 1.19 and 55.1% below the Medical Devices & Instruments industry median of 2.05. Nipro's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Nipro (TSE:8086), the current PB Ratio is 0.92 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nipro (TSE:8086) Overvalued in 2026?
Based on GuruFocus' analysis, Nipro stock appears to be overvalued.
The current stock price of 円1,552.50 is trading 6.6% above its estimated GF Value™ of 円1,457.04.
GuruFocus considers Nipro to be Fairly Valued.
Key valuation signals for TSE:8086:
PB Ratio: 0.92 (23% below median its 10-year median of 1.19)
GF Value™: 円1,457.04 vs. price of 円1,552.50 (6.6% above fair value)
Industry Position: 55.1% below the Medical Devices & Instruments median (#143 of 788)
No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
70GF Score
Get the complete analysis for TSE:8086
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:8086 has been successfully added to your 
